Asia Pacific Preterm Labor Treatment Market : By Drugs (Tocolytic Drugs (Beta – Mimetic, Calcium Channel Blockers, NSAIDS), Corticosteroids, Magnesium Sulphate, Antibiotics, Others)), By Dosage Form (Tablets, Capsules, Injections), By End user (Hospitals, Pediatric and Neonatal Clinics, Nursing Homes, Pharmacy) and Geography – Asia Pacific Preterm Labor Treatment Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2023

Market Dynamics: Asia Pacific Preterm Labor Treatment Market

Increase in premature birth cases and rapid increase birthrate are major driving factors of preterm labor treatment market. As per WHO statistics, every year 15Mn babies are born. Increase in technological advancements, increasing demand for preterm therapeutics and diagnostics, increase in support of government, increase in R&D investments by market players are expected to propel the growth of preterm labor treatment market. However, lack of awareness, stringent regulatory framework, high costs associated with the treatment will hamper the growth of preterm labor treatment market.

Market Scope: Asia Pacific Preterm Labor Treatment Market

Asia Pacific Preterm Labor Treatment market is segmented on the basis of drugs, dosage form, end user and geographical regions

Based on the drugs, Asia Pacific Preterm Labor Treatment market is segmented into the following

• Tocolytic Drugs
• Beta – Mimetic
• Calcium Channel Blockers
• NSAIDS
• Corticosteroids
• Magnesium Sulphate
• Antibiotics
• Others

Based on the Dosage form, Asia Pacific Preterm Labor Treatment market is segmented into the following

• Tablets
• Capsules
• Injection

Based on End user, Asia Pacific Preterm Labor Treatment Market is segmented into the following:

• Hospitals
• Pediatric and Neonatal Clinics
• Nursing Homes
• Pharmacy

Country Analysis: Asia Pacific Preterm Labor Treatment Market

Asia Pacific preterm labor treatment market is divided into countries, Japan, China, India, Australia & New Zealand, ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others), South Korea and Rest of Asia-Pacific. Asia Pacific is anticipated to show significant growth in preterm labor treatment market owing to increase in awareness coupled with disposable income of developing economies, growing population pool. Increase incidences in the preterm births enables propel the growth of preterm labor treatment market in Asia Pacific. Rise in participation of public and private establishments in organizing awareness programs regarding the child birth, pregnancy, preterm birth further enhance the demand for preterm labor treatment.

Competition Assessment: Asia Pacific Preterm Labor Treatment Market

Key players’ profiles in the global Asia Pacific Preterm Labor Treatment Market include

• Pfizer (U.S.)
• Novartis (Switzerland)
• Merck & Co (U.S.)
• Sanofi (France)
• Johnson and Johnson (U.S.)
• GlaxoSmithKline (UK)
• AstraZeneca (UK)
• Cipla (India)

Key Features of the Report:

• The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)

• The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies

• The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market

• The report tracks recent innovations, key developments and startup’s details that are actively working in the market

• The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario

• The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

1. Executive Summary
2. Asia Pacific Preterm Labor Treatment Market Introduction
2.1. Asia Pacific Preterm Labor Treatment Market – Taxonomy
2.2. Asia Pacific Preterm Labor Treatment Market –Definitions
2.2.1. Drugs
2.2.2. Dosage Form
2.2.3. End User
3. Asia Pacific Preterm Labor Treatment Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Asia Pacific Preterm Labor Treatment Market Dynamic Factors – Impact Analysis
3.6. Asia Pacific Preterm Labor Treatment Market – Competition Landscape
3.7. Epidemiology
4. Asia Pacific Preterm Labor Treatment Market Analysis,2013 – 2017 and Forecast, 2018 – 2024
4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market OpportunityAnalysis
5. Asia Pacific Preterm Labor Treatment Market, By Drugs, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.1. Tocolytic Drugs
5.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Beta – Mimetic
5.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Calcium Channel Blockers
5.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. NSAIDS
5.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Corticosteroids
5.5.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
5.6. Magnesium Sulphate
5.6.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.6.3. Market Opportunity Analysis
5.7. Antibiotics
5.7.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.7.3. Market Opportunity Analysis
5.8. Others
5.8.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.8.3. Market Opportunity Analysis
6. Asia Pacific Preterm Labor Treatment Market Forecast, By Dosage Form,2013 – 2017 and Forecast, 2018 – 2024
6.1. Tablets
6.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Capsules
6.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Injection
6.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
7. Asia Pacific Preterm Labor Treatment Market Forecast, By End User, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.1. Hospitals
7.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Pediatric and Neonatal Clinics
7.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Nursing Homes
7.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Pharmacy
7.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
8. Asia Pacific Preterm Labor Treatment Market Forecast, By Country, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
8.1. Japan
8.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. China
8.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. India
8.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Australia & New Zealand
8.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. ASEAN
8.5.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. South Korea
8.6.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
8.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.6.3. Market Opportunity Analysis
8.7. Rest of Asia Pacific
8.7.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
8.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.7.3. Market Opportunity Analysis
8.8. Asia Pacific Preterm Labor Treatment Market – Opportunity Analysis Index, By Drugs, By Dosage Form, By End User and Country, 2018 – 2024
9. Japan Preterm Labor Treatment Market Analysis,2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
9.1. Drugs Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
9.1.1. Tocolytic Drugs
9.1.2. Beta – Mimetic
9.1.3. Calcium Channel Blockers
9.1.4. NSAIDS
9.1.5. Corticosteroids
9.1.6. Magnesium Sulphate
9.1.7. Antibiotics
9.1.8. Others
9.2. Dosage Form Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.2.1. Tablets
9.2.2. Capsules
9.2.3. Injection
9.3. End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.3.1. Hospitals
9.3.2. Pediatric and Neonatal Clinics
9.3.3. Nursing Homes
9.3.4. Pharmacy
9.4. Japan Preterm Labor Treatment Market – Opportunity Analysis Index, By Drugs, By Dosage Form and By End User, 2018 – 2024
9.5. Japan Preterm Labor Treatment Market Dynamics – Trends
10. China Preterm Labor Treatment Market Analysis,2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
10.1. Drugs Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
10.1.1. Tocolytic Drugs
10.1.2. Beta – Mimetic
10.1.3. Calcium Channel Blockers
10.1.4. NSAIDS
10.1.5. Corticosteroids
10.1.6. Magnesium Sulphate
10.1.7. Antibiotics
10.1.8. Others
10.2. Dosage Form Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Tablets
10.2.2. Capsules
10.2.3. Injection
10.3. End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Hospitals
10.3.2. Pediatric and Neonatal Clinics
10.3.3. Nursing Homes
10.3.4. Pharmacy
10.4. China Preterm Labor Treatment Market – Opportunity Analysis Index, By Drugs, By Dosage Form and By End User, 2018 – 2024
10.5. China Preterm Labor Treatment Market Dynamics – Trends
11. India Preterm Labor Treatment Market Analysis,2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
11.1. Drugs Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
11.1.1. Tocolytic Drugs
11.1.2. Beta – Mimetic
11.1.3. Calcium Channel Blockers
11.1.4. NSAIDS
11.1.5. Corticosteroids
11.1.6. Magnesium Sulphate
11.1.7. Antibiotics
11.1.8. Others
11.2. Dosage Form Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Tablets
11.2.2. Capsules
11.2.3. Injection
11.3. End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Hospitals
11.3.2. Pediatric and Neonatal Clinics
11.3.3. Nursing Homes
11.3.4. Pharmacy
11.4. India Preterm Labor Treatment Market – Opportunity Analysis Index, By Drugs, By Dosage Form and By End User, 2018 – 2024
11.5. India Preterm Labor Treatment Market Dynamics – Trends
12. Australia & New Zealand Preterm Labor Treatment Market Analysis,2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
12.1. Drugs Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
12.1.1. Tocolytic Drugs
12.1.2. Beta – Mimetic
12.1.3. Calcium Channel Blockers
12.1.4. NSAIDS
12.1.5. Corticosteroids
12.1.6. Magnesium Sulphate
12.1.7. Antibiotics
12.1.8. Others
12.2. Dosage Form Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Tablets
12.2.2. Capsules
12.2.3. Injection
12.3. End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Hospitals
12.3.2. Pediatric and Neonatal Clinics
12.3.3. Nursing Homes
12.3.4. Pharmacy
12.4. Australia & New Zealand Preterm Labor Treatment Market – Opportunity Analysis Index, By Drugs, By Dosage Form and By End User, 2018 – 2024
12.5. Australia & New Zealand Preterm Labor Treatment Market Dynamics – Trends
13. ASEAN Preterm Labor Treatment Market Analysis,2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
13.1. Drugs Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
13.1.1. Tocolytic Drugs
13.1.2. Beta – Mimetic
13.1.3. Calcium Channel Blockers
13.1.4. NSAIDS
13.1.5. Corticosteroids
13.1.6. Magnesium Sulphate
13.1.7. Antibiotics
13.1.8. Others
13.2. Dosage Form Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Tablets
13.2.2. Capsules
13.2.3. Injection
13.3. End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Hospitals
13.3.2. Pediatric and Neonatal Clinics
13.3.3. Nursing Homes
13.3.4. Pharmacy
13.4. ASEAN Preterm Labor Treatment Market – Opportunity Analysis Index, By Drugs, By Dosage Form and By End User, 2018 – 2024
13.5. ASEAN Preterm Labor Treatment Market Dynamics – Trends
14. South Korea Preterm Labor Treatment Market Analysis,2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
14.1. Drugs Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
14.1.1. Tocolytic Drugs
14.1.2. Beta – Mimetic
14.1.3. Calcium Channel Blockers
14.1.4. NSAIDS
14.1.5. Corticosteroids
14.1.6. Magnesium Sulphate
14.1.7. Antibiotics
14.1.8. Others
14.2. Dosage Form Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.2.1. Tablets
14.2.2. Capsules
14.2.3. Injection
14.3. End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Hospitals
14.3.2. Pediatric and Neonatal Clinics
14.3.3. Nursing Homes
14.3.4. Pharmacy
14.4. South Korea Preterm Labor Treatment Market – Opportunity Analysis Index, By Drugs, By Dosage Form and By End User, 2018 – 2024
14.5. South Korea Preterm Labor Treatment Market Dynamics – Trends
15. Rest of Asia Pacific Preterm Labor Treatment Market Analysis,2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
15.1. Drugs Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
15.1.1. Tocolytic Drugs
15.1.2. Beta – Mimetic
15.1.3. Calcium Channel Blockers
15.1.4. NSAIDS
15.1.5. Corticosteroids
15.1.6. Magnesium Sulphate
15.1.7. Antibiotics
15.1.8. Others
15.2. Dosage Form Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.2.1. Tablets
15.2.2. Capsules
15.2.3. Injection
15.3. End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.3.1. Hospitals
15.3.2. Pediatric and Neonatal Clinics
15.3.3. Nursing Homes
15.3.4. Pharmacy
15.4. Rest of Asia Pacific Preterm Labor Treatment Market – Opportunity Analysis Index, By Drugs, By Dosage Form and By End User, 2018 – 2024
15.5. Rest of Asia Pacific Preterm Labor Treatment Market Dynamics – Trends
16. Competition Landscape
16.1. Strategic Dashboard of Top Market Players
16.2. Company Profiles (Introduction, Financial Analysis, Drugs& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
16.2.1. Pfizer (U.S.)
16.2.2. Novartis (Switzerland)
16.2.3. Merck & Co (U.S.)
16.2.4. Sanofi (France)
16.2.5. Johnson and Johnson (U.S.)
16.2.6. GlaxoSmithKline (UK)
16.2.7. AstraZeneca (UK)
16.2.8. Cipla (India)
17. Research Methodology
18. Key Assumptions and Acronyms

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

ASK AN ANALYST

Request Customisation